 All right, I wanted to talk about the vaccine. So as you know, Pfizer came out, was it now over a week ago and said that they have a vaccine that's 90% effective. I mean, 90% effective is off the charts. I mean, nobody, nobody, nobody expected that a vaccine would have 90% effectiveness. And you know, Pfizer came out and announced it and it was a huge deal. So a few things that I found interesting in the story about the vaccine. First of all, the first thing to note about the vaccine is, thank you, Thomas, is how fast it was produced. I mean, wow, it's what, seven months. That is a world record for vaccine development. Vaccines in the past have taken decades, years, if not decades. Vaccine production of finding an effective vaccine is very, very, very difficult. And I think this is a dramatic indication of how far biotech has advanced and how far the science has advanced. And a real testament to the human mind and to the private sector and to biotech companies and the pharma industry. We'll talk a little bit about pharma and biotech in a minute, but a real testament to the science and the advancements and the understanding that we have now of how viruses work and how the human immune system works. And, you know, so terrific, terrific, amazing achievements. We should definitely be celebrating this. We should definitely be, you know, celebrating the achievement that this has produced. You know, OMG writes that there seems to be two types of rapid prototype vaccines. One is mRNA, mRNA is the fires of vaccine. You know, it's a immunotherapy. It's another one is adenovirus and spike protein, which is a different technology that University of Oxford and other US vaccine makers are using that. I'm not sure the Moderna one, which one that is. I think it's also an mRNA vaccine. But anyway, these are brand new technologies. State of the art. We're not possible just a few years ago. A lot of it has to do with the understanding of the role of RNA, the role of our own immune system, which is constantly developing, constantly improving. It is truly stunning, truly stunning. The advancements we've made and the ability of these biotech companies to do the work as fast as they did. So first, good for Pfizer and I'm hoping Moderna comes out next week with some pretty awesome results as well. That's what the rumors have that they'll announce maybe Monday or Tuesday. So that's, I want to make that point number one. Second point I wanted to make was about who actually developed this vaccine because Pfizer's getting all the credit, but it really wasn't Pfizer. Pfizer is the company that got the vaccine through the FDA approval process. Pfizer is the company that will figure out the logistics of distribution. They will be the ones who market and distribute it. They have the logistical expertise. They have the capacity to scale production so they will be responsible for producing the vaccine. But Pfizer did not do the science behind this vaccine. The science behind this vaccine was done by a, actually by a German company. By a company called BioNTech, that's how you pronounce the name, B-I-O-N-T-E-C-K-C-H, BioNTech. A company was founded in Mainz in Germany in 2008. A company that does, really was focused on immunotherapeutic cancer drugs. So immunotherapy, again, is using our own immune system to fight cancer. That was the basis on which they did it. Pfizer did not take $300 million to develop the vaccine. Pfizer took the money from warp speed in order to manufacture and distribute. In other words, they took the money to sell the vaccine to the United States, to consumers in the United States, the US government. Not a single dollar, American dollar, went into the development of this vaccine. The development of this vaccine was funded by this BioNTech company in Germany with Pfizer. Pfizer got the money, basically they got the money for production and distribution of the vaccine. Not the actual science behind it. What's fascinating about this company, and some of you really should block your ears now because this is gonna be very, very, very offensive to some people who typically listen to my show. So, I gave you a trigger warning. I've given you enough time to shut this down, to press stop, to plug your ears or whatever. But the BioNTech is a company was founded by a husband and wife duo, husband and wife duo, trigger warning now. And then the names of Uga, Sahin, and Oslem, Tureci. And shockingly, and the impossibility of this is truly amazing. Sahin and Tureci are children of Turkish immigrants to Germany. Turkish immigrants to Germany. Oh my God, that is impossible. Turkish immigrants to Germany are Muslims and they're gonna turn, I mean, the only purpose of them immigrating to Germany is to turn Germany into part of the Kalifat. And yet, here they are, here they are, children of Turkish, Muslim, immigrants. You know, one of them, one of them, the father worked at a Ford factory, the other one, or a worker, manual worker, and the other one was actually a doctor, you know, the Turks, doctors. And here they are. So the husband is the CEO, the wife, a woman, God, a woman. Is the chief medical officer? They, this isn't the first biotech company they started. The first biotech company they started was in 2001. It was called Gandy-Med Pharmaceuticals and it was sold, it was sold in 2016 for 1.3 billion euros, 1.3 billion euros. So these, this couple are probably billionaires, if not they're worth many hundreds of millions. And it was sold to a Japanese pharma company. In 2008, they founded BioNTech. So these people ran at two companies. I mean, amazing, amazing entrepreneurs. BioNTech is developing these cancer immunotherapies. They research-centered on messenger RNA, mRNA. And it turns out that mRNA can be used for the development of vaccines. And when corona hits, now they had been working with Pfizer on a flu vaccine. And when March hit, when corona hits, they pivoted. And they agreed to work with Pfizer on applying the technology that they already had, they're applying the technology that they had worked with Pfizer on for the flu vaccine. They pivoted to working on a coronavirus vaccine. And they did it, they were the first ones, they were the first ones to actually develop this. You know, who many, we won't know how many lives these people have saved. We'll have saved in Europe and the rest of the world. You know, this is true breakthrough type technology. This is the first vaccine developed with this kind of technology. As I said, Moderna is using a similar technology, mRNA technology as well. Moderna is an American BioNTech company. But this is truly amazing. Now, just to be clear, Pfizer was not very involved in the science. Pfizer primarily took care of dealing with the FDA and dealing with European regulators and other regulators. So Pfizer managed the clinical trials. For that you need infrastructure and you need a lot of money. And Pfizer is responsible for clinical trials, by the way, in the U.S. while the BioNTech conducted their own clinical trials in Germany. And Pfizer is done all the late stage, the global late stage trials. And Pfizer is responsible for the manufacturing and distribution of this vaccine. We'll get to distribution in a minute because it is very difficult to distribute this. So we're talking about an interesting partnership. Now, one of the issues about partnership, one of the interesting aspects of this is this is kind of typically what pharmaceutical companies in the United States have become because of regulations, because of constraints, because of the bad rap pharmaceutical companies get. The pharmaceutical companies do very little basic science anymore. What the pharmaceutical companies are really, really, really good at is FDA trials, going through the FDA process, manufacturing and distribution and marketing. That's what pharma is good at. And what they do is they let BioNTech companies do the science and then they buy either the drugs or the company, the whole company, they buy it. Once it is proved efficacious to some extent. And then once it is efficacious, they take that drug and they manufacture it and they distribute it and they do the marketing and they get it approved by the FDA and they do all the things that you need to do. So big pharma has become, I'm a big fan of big pharma, so don't take this as an insult. It's just a reality because of the way they're regulated. What they've become is primarily a regulatory marketing, manufacturing, distribution entities. They are no longer huge entities that have real power when it comes to the science. The science is done by small biotech, innovative biotech companies, and then the biotech company builds itself up to sell to pharma that then can leverage that and get them through the FDA and do all that kind of stuff. I mean, hugely value-adding, you need somebody like that and given the regulations that we have, you need somebody who can deal with the regulators and that's what big pharma is doing. So incredibly valuable. I thought that was interesting. And the story of these entrepreneurs is a terrific story. It's a story that I hope is told over and over and over again and that we kind of internalize. By the way, the CEO of Pfizer, the CEO of Pfizer is a guy named Dr. Albert Buller who seems like a good guy. And again, Pfizer's done a really good job getting these trials done and getting the FDA to prove, hopefully, to prove next week the drug for distribution. But Albert, and again, you might want to block, yes, but Albert Buller is also an immigrant, in this case to the United States and in this case from Greece. So I don't know, you know, I heard these immigrants are useless, but at least some of them seem to be quite productive. Finally, one other thing about the Pfizer vaccine and this is gonna be true of Moderna, one of the problems with these, it looks like these mRNA vaccines is that they're very, very unstable, let's call them. That is, the vaccine requires that it be stored at extremely cold temperatures. Now, we're talking about minus 80 Celsius or minus 112 degrees Fahrenheit. I bet somewhere else it's 90-something degrees Fahrenheit, but anyway, really cold. The kind of cold that would kill you in five minutes if you went in, even if you were wearing like a snowsuit and everything. I mean, colder than it gets in Michigan. And that's cold, because Michigan is really cold, as Jennifer will tell you, right? Really, really, this is Antarctica-like cold in the worst, in the worst time, right? Now, this is the problem. You got millions and millions of these, right? Because every human being is gonna have to get two shots, right? So you got two doses for every human being that's, let's say that's 700 million doses in the United States. And then globally, you've got billions of these. And you've got to store this at minus 80 Celsius. You've got to transport it in dry ice. As far as I know, there's just not enough dry ice available to do this. So think about now the logistics, the infrastructure that you have to build in order to be able to transport the vaccine. And, you know, Henry asked his operation, warp speed gonna start manufacturing now. Imagine if the government had to do this. Now, you could argue maybe the US Army, the military could do it, given that, you know, they deploy forces all over the world, they do this. But minus 80 degrees Celsius, how are you gonna do this? Well, unsurprising to me, but maybe to some of you, it's not the government that's gonna solve this problem. Although, from what I hear, governments are running around trying to buy any refrigerator that can store stuff at that cold, around and they're buying huge quantities of them. But no, this is not gonna be solved by governments. Who's gonna solve this? Well, UPS and DHL and FedEx. UPS is building two giant freezer farms, capable of super cooling millions of vials of a COVID-19 vaccine. There are gonna be two facilities at the beginning, at least, one is in Louisville, Kentucky. Louisville, Kentucky is of course a hub for UPS. They can ship everything out of there. And the other one is in the Netherlands, which is a big UPS hub for Europe and the rest of the world. They're gonna have 600 deep freezers. They can each hold 48,000 vials of vaccine at temperatures as low as minus 80 degrees Celsius. From there, they will load these vaccines up onto airplanes, trucks and other delivery vehicles. On dry ice, so they are, they've done this before because they shipped medicines around the world anyway. But now they have to ramp up production of dry ice, production of containers that use dry ice to cool. All of this is happening. UPS, FedEx, DHL, in other words, the private sector is ramping up the production in order to do this mass distribution. And they expect to be airlifting thousands of tons of this kind of stuff all over the United States and all over Europe and all over the world ultimately. I mean, I get a little teary eyed, I have to say, because this stuff excites me. This stuff is cool. I mean, I know you guys probably want me to talk about the election and Biden and Trump. Who the, I mean, this stuff is interesting, right? The creation of a vaccine, the science that goes into it, the logistics of it, all the everything, the thinking, everything that has to go into this is so amazing. It's so exciting. And then the infrastructure and the ability of the private sector to adapt, and the people say, oh no, oh no, the private sector short-term thinking, really? I mean, UPS is building these farms way ahead of any government institution buying the refrigerators. Why? Because no, it is the private sector that is long-term thinking. Long-term thinking. So, to me, this is amazing. Leave it to the private sector. Keep the government away from this. Away, please, away, away. I mean, maybe if they fund it, it'll be relatively okay. But if they have to build it, if they have to transport it, if they have to, no, stay away, government. It is truly a beautiful thing to watch the private sector rise up in an emergency to deal with an emergency. And if they'd left COVID to the private sector, we wouldn't be where we are today. We'd be in much better shape. By the way, we probably would be already taking the vaccine. I'm eager to get the vaccine. I know some of you don't like that, but I'm eager to get, take the vaccine. And, but, you know, we've known these results for a few weeks now. Why isn't it shipping already? Oh, it turns out the FDA has to convene. It has to evaluate the results. It then has to deliberate. It has to discuss. It has to accept the opposition views, you know. So they will take about a month to grant emergency approval in an emergency. The private sector, when there's an emergency in the private sector, that means it's an emergency, which means, I mean, it's shocking, I know. But it means you do it fast. You act fast. You move quickly. That's what it means. Don't tell the government, but that's what it means. Limbeck, thank you. Thank you. Really appreciate that. Anyway, to me, this is fascinating. By the way, every one of these freezers that UPS is buying costs anyway between 10 to $15,000. You know, so these farms are costing millions of dollars, millions of millions of dollars. These are ultra low temperature freezers, special freezers, 10 to 15. So each one of these farms, freezer farms right now is at a minimal cost of $6 million. That's just for the freezers. Not talking about the electricity, the wiring, all, everything else. That's private companies. Now, yes, the government is probably gonna pay for the actual vaccine. But if not, the government insurance companies would do it and we would have had it by now. Anyway, I think this is cool. This is much more exciting to me than the next topic we're gonna move to. What we need today, what I call the new intellectual would be any man or woman who is willing to think. Meaning any man or woman who knows that man's life must be guided by reason, by the intellect, not by feelings, wishes, whims, or mystic revelations. Any man or woman who values his life and who does not want to give in to today's cult of despair, cynicism, and impotence and does not intend to give up the world to the dark ages and to the role of the collectivist, broads. All right, before we go on, reminder, please like the show. We've got 163 live listeners right now, 30 likes. That should be at least 100. I figure at least 100 of you actually like the show. Maybe they're like 60 of the Matthews out there who hate it, but at least the people who are liking it, I wanna see a thumbs up, there you go. Start liking it, I wanna see that go to 100. All it takes is a click of a thing, whether you're looking at this. And you know the likes matter. It's not an issue of my ego. It's an issue of the algorithm. The more you like something, the more the algorithm likes it. So if you don't like the show, give it a thumbs down. Let's see your actual views being reflected in the likes. But if you like it, don't just sit there, help get the show promoted. Of course, you should also share. And you can support the show at youronbrookshow.com slash support on Patreon or Subscribestar or locals and show your support for the work, for the value, hopefully you're receiving from this. And of course, don't forget, if you're not a subscriber, even if you just come here to troll, or even if you're here like Matthew to defend Marx, then you should subscribe because that way you'll know when to show up. You'll know what shows are on, when they're on. You'll get notified, right? So yes, like, share, subscribe, support. Like, share, subscribe, support. There you go. Easy. Do one, all of those, please.